Suzhou Zelgen Biopharmaceuticals Co., Ltd. researches and develops, manufactures, and sells medicines in the People's Republic of China. It offers small molecule and recombinant protein drugs for the treatment of liver cancer, non-small cell lung cancer, colorectal cancer, thyroid cancer, nasopharyngeal carcinomas, myelofibrosis, hemorrhage, and hepatobiliary diseases. The company was founded in 2009 and is based in Kunshan, the People's Republic of China.

Suzhou Zelgen Biopharmaceuticals Co., Ltd.

Revenue

Price Targets

# of Analysts

Consensus Recommendation

EBITDA

EBIT

Free Cash Flow

FFO / Share

AFFO / Share

NAV / Share

Book Value / Share

CapEx

Estimates	Dec '23 (A)	Dec '24 (A)	Dec '25 (E)
Mean	CN¥429.00	CN¥600.00	CN¥843.93
Median	CN¥423.00	CN¥570.00	CN¥840.36
Actual	CN¥386.44	CN¥533.91	—
High	CN¥459.00	CN¥722.00	CN¥869.00
Low	CN¥405.00	CN¥508.00	CN¥826.00
Standard Deviation	CN¥22.45	CN¥89.90	CN¥17.56
# of Estimates	3	3	4